Ztilido: Clinical trial started

Scilex began a dermal safety trial to evaluate Ztilido lidocaine patch 1.8%. In May, Scilex began an open-label, U.S. pivotal bioequivalence trial of Ztilido. Scilex plans to complete both trials in 4...